CDH2 and hepatocellular carcinoma: There are multiple factors affecting the therapeutic efficacy for HCC, including epithelial–mesenchymal transformation (EMT), which plays a crucial part in HCC progression and is characterized by the reducing expression of E-cadherin (epithelial marker) and increase in N-cadherin (mesenchymal marker) [4].